

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.21833600 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.21833600 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.86037305 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.86037305 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.44656278 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.22933681 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 5.81105939 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 5.81105939 |
| 9 | tryptophan catabolic process (GO:0006569) | 5.81105939 |
| 10 | bile acid biosynthetic process (GO:0006699) | 5.76544653 |
| 11 | kynurenine metabolic process (GO:0070189) | 5.73188003 |
| 12 | alpha-linolenic acid metabolic process (GO:0036109) | 5.54024325 |
| 13 | high-density lipoprotein particle remodeling (GO:0034375) | 5.49025911 |
| 14 | glyoxylate metabolic process (GO:0046487) | 5.48386788 |
| 15 | tryptophan metabolic process (GO:0006568) | 5.46065601 |
| 16 | urea metabolic process (GO:0019627) | 5.44535794 |
| 17 | urea cycle (GO:0000050) | 5.44535794 |
| 18 | exogenous drug catabolic process (GO:0042738) | 5.43194221 |
| 19 | negative regulation of fibrinolysis (GO:0051918) | 5.30338015 |
| 20 | sulfur amino acid catabolic process (GO:0000098) | 5.30254598 |
| 21 | complement activation, alternative pathway (GO:0006957) | 5.20593417 |
| 22 | regulation of protein activation cascade (GO:2000257) | 5.19104100 |
| 23 | cysteine metabolic process (GO:0006534) | 5.17174551 |
| 24 | regulation of fibrinolysis (GO:0051917) | 5.12009397 |
| 25 | protein carboxylation (GO:0018214) | 5.04556977 |
| 26 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.04556977 |
| 27 | reverse cholesterol transport (GO:0043691) | 5.02462858 |
| 28 | nitrogen cycle metabolic process (GO:0071941) | 4.98931863 |
| 29 | regulation of cholesterol esterification (GO:0010872) | 4.94433385 |
| 30 | serine family amino acid catabolic process (GO:0009071) | 4.91639594 |
| 31 | bile acid metabolic process (GO:0008206) | 4.90825929 |
| 32 | behavioral response to nicotine (GO:0035095) | 4.90248224 |
| 33 | plasma lipoprotein particle remodeling (GO:0034369) | 4.85595873 |
| 34 | protein-lipid complex remodeling (GO:0034368) | 4.85595873 |
| 35 | macromolecular complex remodeling (GO:0034367) | 4.85595873 |
| 36 | regulation of complement activation (GO:0030449) | 4.85549443 |
| 37 | homocysteine metabolic process (GO:0050667) | 4.69958526 |
| 38 | aromatic amino acid family metabolic process (GO:0009072) | 4.66183601 |
| 39 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.62540684 |
| 40 | alpha-amino acid catabolic process (GO:1901606) | 4.56548706 |
| 41 | lysine metabolic process (GO:0006553) | 4.55137605 |
| 42 | lysine catabolic process (GO:0006554) | 4.55137605 |
| 43 | tyrosine metabolic process (GO:0006570) | 4.54433064 |
| 44 | amino-acid betaine metabolic process (GO:0006577) | 4.50829725 |
| 45 | phospholipid efflux (GO:0033700) | 4.48502652 |
| 46 | negative regulation of sterol transport (GO:0032372) | 4.44651989 |
| 47 | negative regulation of cholesterol transport (GO:0032375) | 4.44651989 |
| 48 | glutamate metabolic process (GO:0006536) | 4.44372929 |
| 49 | low-density lipoprotein particle remodeling (GO:0034374) | 4.42141443 |
| 50 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.34028259 |
| 51 | oxidative demethylation (GO:0070989) | 4.33911214 |
| 52 | triglyceride homeostasis (GO:0070328) | 4.33873036 |
| 53 | acylglycerol homeostasis (GO:0055090) | 4.33873036 |
| 54 | cellular ketone body metabolic process (GO:0046950) | 4.31418257 |
| 55 | cellular modified amino acid catabolic process (GO:0042219) | 4.26308853 |
| 56 | cellular amino acid catabolic process (GO:0009063) | 4.24977238 |
| 57 | coenzyme catabolic process (GO:0009109) | 4.24371438 |
| 58 | * regulation of triglyceride catabolic process (GO:0010896) | 4.18216199 |
| 59 | cholesterol efflux (GO:0033344) | 4.15678534 |
| 60 | bile acid and bile salt transport (GO:0015721) | 4.14778821 |
| 61 | plasma lipoprotein particle clearance (GO:0034381) | 4.11493963 |
| 62 | indolalkylamine metabolic process (GO:0006586) | 4.10985382 |
| 63 | plasma lipoprotein particle assembly (GO:0034377) | 4.07352470 |
| 64 | glycine metabolic process (GO:0006544) | 4.06098645 |
| 65 | amine catabolic process (GO:0009310) | 4.02247429 |
| 66 | cellular biogenic amine catabolic process (GO:0042402) | 4.02247429 |
| 67 | cellular glucuronidation (GO:0052695) | 4.02183763 |
| 68 | imidazole-containing compound metabolic process (GO:0052803) | 4.01896753 |
| 69 | omega-hydroxylase P450 pathway (GO:0097267) | 3.99428576 |
| 70 | ethanol oxidation (GO:0006069) | 3.98024784 |
| 71 | sulfation (GO:0051923) | 3.96247528 |
| 72 | serine family amino acid metabolic process (GO:0009069) | 3.91549603 |
| 73 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.89043530 |
| 74 | benzene-containing compound metabolic process (GO:0042537) | 3.84102233 |
| 75 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.83083044 |
| 76 | arginine metabolic process (GO:0006525) | 3.80239825 |
| 77 | plasma lipoprotein particle organization (GO:0071827) | 3.79462839 |
| 78 | serine family amino acid biosynthetic process (GO:0009070) | 3.76247374 |
| 79 | phospholipid homeostasis (GO:0055091) | 3.75917490 |
| 80 | fibrinolysis (GO:0042730) | 3.74710819 |
| 81 | ketone body metabolic process (GO:1902224) | 3.74274969 |
| 82 | regulation of cholesterol homeostasis (GO:2000188) | 3.72337471 |
| 83 | drug catabolic process (GO:0042737) | 3.72025610 |
| 84 | regulation of bile acid biosynthetic process (GO:0070857) | 3.71871374 |
| 85 | short-chain fatty acid metabolic process (GO:0046459) | 3.69329289 |
| 86 | epoxygenase P450 pathway (GO:0019373) | 3.68179799 |
| 87 | complement activation, classical pathway (GO:0006958) | 3.67638453 |
| 88 | organic acid catabolic process (GO:0016054) | 3.65267349 |
| 89 | carboxylic acid catabolic process (GO:0046395) | 3.65267349 |
| 90 | protein-lipid complex assembly (GO:0065005) | 3.64668789 |
| 91 | gamma-aminobutyric acid transport (GO:0015812) | 3.64040649 |
| 92 | complement activation (GO:0006956) | 3.63676145 |
| 93 | positive regulation of lipid catabolic process (GO:0050996) | 3.60109805 |
| 94 | negative regulation of lipase activity (GO:0060192) | 3.59776793 |
| 95 | protein activation cascade (GO:0072376) | 3.59464085 |
| 96 | flavonoid metabolic process (GO:0009812) | 3.59020325 |
| 97 | cytolysis (GO:0019835) | 3.56905372 |
| 98 | cholesterol homeostasis (GO:0042632) | 3.56870342 |
| 99 | blood coagulation, intrinsic pathway (GO:0007597) | 3.56817761 |
| 100 | protein-lipid complex subunit organization (GO:0071825) | 3.56478097 |
| 101 | aspartate family amino acid catabolic process (GO:0009068) | 3.55320514 |
| 102 | uronic acid metabolic process (GO:0006063) | 3.52913785 |
| 103 | glucuronate metabolic process (GO:0019585) | 3.52913785 |
| 104 | cofactor catabolic process (GO:0051187) | 3.52249876 |
| 105 | sterol homeostasis (GO:0055092) | 3.51752546 |
| 106 | DNA deamination (GO:0045006) | 3.50159225 |
| 107 | acetyl-CoA metabolic process (GO:0006084) | 3.49313498 |
| 108 | negative regulation of protein activation cascade (GO:2000258) | 3.49121633 |
| 109 | 2-oxoglutarate metabolic process (GO:0006103) | 3.45440395 |
| 110 | aldehyde catabolic process (GO:0046185) | 3.44430246 |
| 111 | response to pheromone (GO:0019236) | 3.39074019 |
| 112 | indole-containing compound metabolic process (GO:0042430) | 3.37363536 |
| 113 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.28696080 |
| 114 | detection of light stimulus involved in visual perception (GO:0050908) | 3.28696080 |
| 115 | S-adenosylmethionine metabolic process (GO:0046500) | 3.24908006 |
| 116 | alkaloid metabolic process (GO:0009820) | 3.21159924 |
| 117 | drug metabolic process (GO:0017144) | 3.17090278 |
| 118 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.11207548 |
| 119 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.08944615 |
| 120 | dopamine transport (GO:0015872) | 3.08187764 |
| 121 | amino acid salvage (GO:0043102) | 2.97844189 |
| 122 | L-methionine salvage (GO:0071267) | 2.97844189 |
| 123 | L-methionine biosynthetic process (GO:0071265) | 2.97844189 |
| 124 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.93197454 |
| 125 | NADH dehydrogenase complex assembly (GO:0010257) | 2.93197454 |
| 126 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.93197454 |
| 127 | phenylpropanoid metabolic process (GO:0009698) | 2.91907960 |
| 128 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.84181186 |
| 129 | cell proliferation in forebrain (GO:0021846) | 2.80421291 |
| 130 | protein polyglutamylation (GO:0018095) | 2.79115159 |
| 131 | cellular response to ATP (GO:0071318) | 2.77705887 |
| 132 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.76438008 |
| 133 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.76438008 |
| 134 | protein complex biogenesis (GO:0070271) | 2.74721251 |
| 135 | transmission of nerve impulse (GO:0019226) | 2.74330936 |
| 136 | primary amino compound metabolic process (GO:1901160) | 2.74053390 |
| 137 | negative regulation of mast cell activation (GO:0033004) | 2.73664402 |
| 138 | somite development (GO:0061053) | 2.73440460 |
| 139 | neuronal action potential (GO:0019228) | 2.72654572 |
| 140 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.69853507 |
| 141 | piRNA metabolic process (GO:0034587) | 2.69631940 |
| 142 | regulation of glucokinase activity (GO:0033131) | 2.68836069 |
| 143 | regulation of hexokinase activity (GO:1903299) | 2.68836069 |
| 144 | presynaptic membrane assembly (GO:0097105) | 2.67435863 |
| 145 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.66925708 |
| 146 | serotonin metabolic process (GO:0042428) | 2.66731041 |
| 147 | nucleobase catabolic process (GO:0046113) | 2.66412906 |
| 148 | negative regulation of astrocyte differentiation (GO:0048712) | 2.61970996 |
| 149 | kidney morphogenesis (GO:0060993) | 2.61078668 |
| 150 | regulation of action potential (GO:0098900) | 2.60027184 |
| 151 | retinal cone cell development (GO:0046549) | 2.59872350 |
| 152 | regulation of acrosome reaction (GO:0060046) | 2.59291596 |
| 153 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.58913325 |
| 154 | heme transport (GO:0015886) | 2.57511810 |
| 155 | positive regulation of fatty acid transport (GO:2000193) | 2.57082001 |
| 156 | epithelial cilium movement (GO:0003351) | 2.54499866 |
| 157 | positive regulation of fatty acid oxidation (GO:0046321) | 2.54259492 |
| 158 | reflex (GO:0060004) | 2.52589112 |
| 159 | vitamin biosynthetic process (GO:0009110) | 2.50912020 |
| 160 | postsynaptic membrane organization (GO:0001941) | 2.49663118 |
| 161 | opsonization (GO:0008228) | 2.49395876 |
| 162 | peristalsis (GO:0030432) | 2.49343487 |
| 163 | L-fucose catabolic process (GO:0042355) | 2.48238079 |
| 164 | fucose catabolic process (GO:0019317) | 2.48238079 |
| 165 | L-fucose metabolic process (GO:0042354) | 2.48238079 |
| 166 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.47516531 |
| 167 | photoreceptor cell development (GO:0042461) | 2.47016250 |
| 168 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.46138774 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.66144668 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.50786740 |
| 3 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.13051022 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.05098072 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.00962716 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.34338303 |
| 7 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.25648090 |
| 8 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.24790255 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.83807832 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.37154662 |
| 11 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.07363566 |
| 12 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.86566820 |
| 13 | VDR_22108803_ChIP-Seq_LS180_Human | 2.84952533 |
| 14 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.53733974 |
| 15 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.50756590 |
| 16 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.37623114 |
| 17 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.26421461 |
| 18 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.25061977 |
| 19 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.10607506 |
| 20 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.06476919 |
| 21 | FUS_26573619_Chip-Seq_HEK293_Human | 2.05358191 |
| 22 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.0024150 |
| 23 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.99978481 |
| 24 | P300_19829295_ChIP-Seq_ESCs_Human | 1.97240817 |
| 25 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.96888005 |
| 26 | EWS_26573619_Chip-Seq_HEK293_Human | 1.86780551 |
| 27 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.77778314 |
| 28 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.77748664 |
| 29 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.74535321 |
| 30 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.72365861 |
| 31 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.66129794 |
| 32 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.64400065 |
| 33 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.63201660 |
| 34 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.62297259 |
| 35 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.61560796 |
| 36 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.60222785 |
| 37 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.59991483 |
| 38 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.58563792 |
| 39 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.57873363 |
| 40 | STAT3_23295773_ChIP-Seq_U87_Human | 1.57048025 |
| 41 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.56427985 |
| 42 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.56427985 |
| 43 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.55319212 |
| 44 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.53879846 |
| 45 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.51683415 |
| 46 | TCF4_23295773_ChIP-Seq_U87_Human | 1.50353218 |
| 47 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.49335894 |
| 48 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.48261637 |
| 49 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.47715378 |
| 50 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.46483581 |
| 51 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.46376420 |
| 52 | AR_25329375_ChIP-Seq_VCAP_Human | 1.45295957 |
| 53 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.44873171 |
| 54 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.44585902 |
| 55 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.42000999 |
| 56 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.41480216 |
| 57 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.37985419 |
| 58 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.37851128 |
| 59 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.37674844 |
| 60 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.37472203 |
| 61 | GATA1_22025678_ChIP-Seq_K562_Human | 1.37010608 |
| 62 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.34859476 |
| 63 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.32837696 |
| 64 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.32784644 |
| 65 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.32737305 |
| 66 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.32249075 |
| 67 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.31435501 |
| 68 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.31261352 |
| 69 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.30259353 |
| 70 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.28719366 |
| 71 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.28719366 |
| 72 | * MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.28421592 |
| 73 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.27796173 |
| 74 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.27746699 |
| 75 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.27067177 |
| 76 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.26468933 |
| 77 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.26468933 |
| 78 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.26307696 |
| 79 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.24583638 |
| 80 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.24479470 |
| 81 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.23654981 |
| 82 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.20724296 |
| 83 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.20161830 |
| 84 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.19699258 |
| 85 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.17971398 |
| 86 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.17376951 |
| 87 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.17269806 |
| 88 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.16781265 |
| 89 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.16239928 |
| 90 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.16239928 |
| 91 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.16154282 |
| 92 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.15701816 |
| 93 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.15126838 |
| 94 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.14750107 |
| 95 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.13125917 |
| 96 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.13055319 |
| 97 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.12502116 |
| 98 | NCOR_22424771_ChIP-Seq_293T_Human | 1.11420186 |
| 99 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.10240407 |
| 100 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.09958492 |
| 101 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.06149271 |
| 102 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.05981306 |
| 103 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.05687373 |
| 104 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.05504863 |
| 105 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.04028518 |
| 106 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.00788783 |
| 107 | * FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.99699754 |
| 108 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.99535746 |
| 109 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.99482235 |
| 110 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.98410635 |
| 111 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.98060110 |
| 112 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.97654100 |
| 113 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.96051373 |
| 114 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.94310218 |
| 115 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.93170532 |
| 116 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.93107167 |
| 117 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.90630970 |
| 118 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.87394176 |
| 119 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.85301232 |
| 120 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.82631591 |
| 121 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.82146721 |
| 122 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.80581598 |
| 123 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.80581598 |
| 124 | * AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.78018475 |
| 125 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.75488930 |
| 126 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.75449808 |
| 127 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.72153862 |
| 128 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.71283899 |
| 129 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.68974469 |
| 130 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.68444091 |
| 131 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.67762783 |
| 132 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.67720986 |
| 133 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.67419562 |
| 134 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.66705505 |
| 135 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.63720958 |
| 136 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.63538302 |
| 137 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.63445914 |
| 138 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.62100832 |
| 139 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.61875069 |
| 140 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.61011561 |
| 141 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.60367787 |
| 142 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.60200706 |
| 143 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.59836082 |
| 144 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.59318759 |
| 145 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.58754694 |
| 146 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.57901215 |
| 147 | CBP_21632823_ChIP-Seq_H3396_Human | 0.57295666 |
| 148 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.57203807 |
| 149 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.56855474 |
| 150 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.55054891 |
| 151 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.54325549 |
| 152 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.54222817 |
| 153 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.53466220 |
| 154 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.52717535 |
| 155 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.52363459 |
| 156 | * MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.51515881 |
| 157 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.51093352 |
| 158 | GATA1_19941826_ChIP-Seq_K562_Human | 0.50915612 |
| 159 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.50635372 |
| 160 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.50543520 |
| 161 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.50165571 |
| 162 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.50026907 |
| 163 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.49947985 |
| 164 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.49880161 |
| 165 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.49846315 |
| 166 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.49826341 |
| 167 | AR_20517297_ChIP-Seq_VCAP_Human | 0.49424120 |
| 168 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.48716401 |
| 169 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.48697334 |
| 170 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.48043491 |
| 171 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.47616216 |
| 172 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.47465825 |
| 173 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.46201124 |
| 174 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.46157029 |
| 175 | GATA2_19941826_ChIP-Seq_K562_Human | 0.45979686 |
| 176 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.45282870 |
| 177 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.44891135 |
| 178 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.43761990 |
| 179 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.43745163 |
| 180 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.43700910 |
| 181 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.43380375 |
| 182 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.43377386 |
| 183 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.42923029 |
| 184 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.42226766 |
| 185 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.42221071 |
| 186 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.41905729 |
| 187 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.41729972 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.04253393 |
| 2 | MP0005360_urolithiasis | 7.39125501 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.30210420 |
| 4 | MP0005365_abnormal_bile_salt | 6.09212184 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.02973024 |
| 6 | MP0003252_abnormal_bile_duct | 3.83805200 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.82984535 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.63865636 |
| 9 | MP0009840_abnormal_foam_cell | 3.32909031 |
| 10 | MP0005083_abnormal_biliary_tract | 3.07327878 |
| 11 | MP0006292_abnormal_olfactory_placode | 3.00659416 |
| 12 | MP0005332_abnormal_amino_acid | 2.87194596 |
| 13 | MP0003195_calcinosis | 2.70029986 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.59980222 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.25061322 |
| 16 | MP0008877_abnormal_DNA_methylation | 2.24995464 |
| 17 | MP0005551_abnormal_eye_electrophysiolog | 2.15323951 |
| 18 | MP0002118_abnormal_lipid_homeostasis | 2.12657357 |
| 19 | MP0004019_abnormal_vitamin_homeostasis | 2.11651224 |
| 20 | MP0002102_abnormal_ear_morphology | 2.10858208 |
| 21 | MP0000609_abnormal_liver_physiology | 2.07871689 |
| 22 | MP0000569_abnormal_digit_pigmentation | 1.90112370 |
| 23 | MP0003868_abnormal_feces_composition | 1.90032144 |
| 24 | MP0003646_muscle_fatigue | 1.89022235 |
| 25 | MP0003880_abnormal_central_pattern | 1.87354177 |
| 26 | MP0001968_abnormal_touch/_nociception | 1.78615355 |
| 27 | MP0002638_abnormal_pupillary_reflex | 1.75441364 |
| 28 | MP0001485_abnormal_pinna_reflex | 1.74923616 |
| 29 | MP0005319_abnormal_enzyme/_coenzyme | 1.74504730 |
| 30 | MP0009745_abnormal_behavioral_response | 1.68776636 |
| 31 | MP0002138_abnormal_hepatobiliary_system | 1.67624743 |
| 32 | MP0004142_abnormal_muscle_tone | 1.66774091 |
| 33 | MP0000631_abnormal_neuroendocrine_gland | 1.65950201 |
| 34 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.61041358 |
| 35 | MP0006276_abnormal_autonomic_nervous | 1.59926764 |
| 36 | MP0002272_abnormal_nervous_system | 1.58464801 |
| 37 | MP0001764_abnormal_homeostasis | 1.52701662 |
| 38 | MP0000372_irregular_coat_pigmentation | 1.51902396 |
| 39 | MP0002254_reproductive_system_inflammat | 1.51625265 |
| 40 | MP0003011_delayed_dark_adaptation | 1.50875933 |
| 41 | MP0002736_abnormal_nociception_after | 1.47132298 |
| 42 | MP0009046_muscle_twitch | 1.47003590 |
| 43 | MP0006072_abnormal_retinal_apoptosis | 1.41442568 |
| 44 | MP0003136_yellow_coat_color | 1.40894082 |
| 45 | MP0009697_abnormal_copulation | 1.39949899 |
| 46 | MP0005645_abnormal_hypothalamus_physiol | 1.38518604 |
| 47 | MP0002160_abnormal_reproductive_system | 1.38363199 |
| 48 | MP0001986_abnormal_taste_sensitivity | 1.37961201 |
| 49 | MP0000604_amyloidosis | 1.37618478 |
| 50 | MP0005253_abnormal_eye_physiology | 1.34848745 |
| 51 | MP0003283_abnormal_digestive_organ | 1.32973222 |
| 52 | MP0004145_abnormal_muscle_electrophysio | 1.32026863 |
| 53 | MP0003718_maternal_effect | 1.31915255 |
| 54 | MP0003656_abnormal_erythrocyte_physiolo | 1.31858432 |
| 55 | MP0005647_abnormal_sex_gland | 1.29400536 |
| 56 | MP0001486_abnormal_startle_reflex | 1.27922657 |
| 57 | MP0005389_reproductive_system_phenotype | 1.25745048 |
| 58 | MP0002653_abnormal_ependyma_morphology | 1.25481980 |
| 59 | MP0002064_seizures | 1.18927898 |
| 60 | MP0005451_abnormal_body_composition | 1.18488513 |
| 61 | MP0003690_abnormal_glial_cell | 1.18301035 |
| 62 | MP0009643_abnormal_urine_homeostasis | 1.17004981 |
| 63 | MP0002735_abnormal_chemical_nociception | 1.15579337 |
| 64 | MP0003329_amyloid_beta_deposits | 1.15529519 |
| 65 | MP0000049_abnormal_middle_ear | 1.13540787 |
| 66 | MP0004133_heterotaxia | 1.11483188 |
| 67 | MP0003705_abnormal_hypodermis_morpholog | 1.11473907 |
| 68 | MP0003787_abnormal_imprinting | 1.09186162 |
| 69 | MP0001501_abnormal_sleep_pattern | 1.08501369 |
| 70 | MP0003119_abnormal_digestive_system | 1.07481007 |
| 71 | MP0008789_abnormal_olfactory_epithelium | 1.07368700 |
| 72 | MP0003635_abnormal_synaptic_transmissio | 1.06945218 |
| 73 | MP0003890_abnormal_embryonic-extraembry | 1.06263388 |
| 74 | MP0003186_abnormal_redox_activity | 1.05171646 |
| 75 | MP0009764_decreased_sensitivity_to | 1.04025025 |
| 76 | MP0002734_abnormal_mechanical_nocicepti | 1.03628108 |
| 77 | MP0000598_abnormal_liver_morphology | 1.01264271 |
| 78 | MP0002557_abnormal_social/conspecific_i | 1.00966001 |
| 79 | MP0005195_abnormal_posterior_eye | 1.00622232 |
| 80 | MP0002572_abnormal_emotion/affect_behav | 0.98700949 |
| 81 | MP0001984_abnormal_olfaction | 0.98016151 |
| 82 | MP0005379_endocrine/exocrine_gland_phen | 0.97916783 |
| 83 | MP0001970_abnormal_pain_threshold | 0.96979036 |
| 84 | MP0002733_abnormal_thermal_nociception | 0.96291320 |
| 85 | MP0002063_abnormal_learning/memory/cond | 0.93979947 |
| 86 | MP0001440_abnormal_grooming_behavior | 0.93748840 |
| 87 | MP0005636_abnormal_mineral_homeostasis | 0.93560754 |
| 88 | MP0002938_white_spotting | 0.93241607 |
| 89 | MP0000427_abnormal_hair_cycle | 0.92851197 |
| 90 | MP0005187_abnormal_penis_morphology | 0.90479720 |
| 91 | MP0005174_abnormal_tail_pigmentation | 0.90449890 |
| 92 | MP0000778_abnormal_nervous_system | 0.90355168 |
| 93 | MP0003938_abnormal_ear_development | 0.89254267 |
| 94 | MP0009763_increased_sensitivity_to | 0.89134962 |
| 95 | MP0004924_abnormal_behavior | 0.88880059 |
| 96 | MP0005386_behavior/neurological_phenoty | 0.88880059 |
| 97 | MP0003937_abnormal_limbs/digits/tail_de | 0.88791290 |
| 98 | MP0004134_abnormal_chest_morphology | 0.87967587 |
| 99 | MP0002822_catalepsy | 0.86010991 |
| 100 | MP0010386_abnormal_urinary_bladder | 0.85448207 |
| 101 | MP0002751_abnormal_autonomic_nervous | 0.85242293 |
| 102 | MP0004147_increased_porphyrin_level | 0.85195079 |
| 103 | MP0004130_abnormal_muscle_cell | 0.85161733 |
| 104 | MP0004742_abnormal_vestibular_system | 0.84540948 |
| 105 | MP0002163_abnormal_gland_morphology | 0.84525904 |
| 106 | MP0009642_abnormal_blood_homeostasis | 0.83562729 |
| 107 | MP0000026_abnormal_inner_ear | 0.83423324 |
| 108 | MP0005535_abnormal_body_temperature | 0.82849093 |
| 109 | MP0002078_abnormal_glucose_homeostasis | 0.82830016 |
| 110 | MP0001529_abnormal_vocalization | 0.82347338 |
| 111 | MP0005670_abnormal_white_adipose | 0.82001247 |
| 112 | MP0001963_abnormal_hearing_physiology | 0.81102390 |
| 113 | MP0002282_abnormal_trachea_morphology | 0.80814160 |
| 114 | MP0001919_abnormal_reproductive_system | 0.80513599 |
| 115 | MP0002752_abnormal_somatic_nervous | 0.78183819 |
| 116 | MP0002067_abnormal_sensory_capabilities | 0.78166949 |
| 117 | MP0001905_abnormal_dopamine_level | 0.77471699 |
| 118 | MP0002971_abnormal_brown_adipose | 0.76781713 |
| 119 | MP0002876_abnormal_thyroid_physiology | 0.76432216 |
| 120 | MP0002909_abnormal_adrenal_gland | 0.75135939 |
| 121 | MP0005376_homeostasis/metabolism_phenot | 0.73443034 |
| 122 | MP0008469_abnormal_protein_level | 0.73383911 |
| 123 | MP0010368_abnormal_lymphatic_system | 0.73046447 |
| 124 | MP0009765_abnormal_xenobiotic_induced | 0.71561310 |
| 125 | MP0003075_altered_response_to | 0.70949060 |
| 126 | MP0000639_abnormal_adrenal_gland | 0.69703610 |
| 127 | MP0005220_abnormal_exocrine_pancreas | 0.67865150 |
| 128 | MP0005334_abnormal_fat_pad | 0.67059475 |
| 129 | MP0006036_abnormal_mitochondrial_physio | 0.66613833 |
| 130 | MP0005084_abnormal_gallbladder_morpholo | 0.65440369 |
| 131 | MP0001661_extended_life_span | 0.64377596 |
| 132 | MP0009384_cardiac_valve_regurgitation | 0.64273778 |
| 133 | MP0005408_hypopigmentation | 0.64152742 |
| 134 | MP0001756_abnormal_urination | 0.63219780 |
| 135 | MP0005448_abnormal_energy_balance | 0.61381949 |
| 136 | MP0008874_decreased_physiological_sensi | 0.58371204 |
| 137 | MP0005266_abnormal_metabolism | 0.55705183 |
| 138 | MP0003638_abnormal_response/metabolism_ | 0.54327956 |
| 139 | MP0005166_decreased_susceptibility_to | 0.52857695 |
| 140 | MP0000579_abnormal_nail_morphology | 0.52594478 |
| 141 | MP0008872_abnormal_physiological_respon | 0.52388684 |
| 142 | MP0002837_dystrophic_cardiac_calcinosis | 0.50460131 |
| 143 | MP0006035_abnormal_mitochondrial_morpho | 0.50237238 |
| 144 | MP0004043_abnormal_pH_regulation | 0.48735275 |
| 145 | MP0003953_abnormal_hormone_level | 0.48264669 |
| 146 | MP0009053_abnormal_anal_canal | 0.47814421 |
| 147 | MP0005167_abnormal_blood-brain_barrier | 0.47005766 |
| 148 | MP0002090_abnormal_vision | 0.46675731 |
| 149 | MP0005646_abnormal_pituitary_gland | 0.43576617 |
| 150 | MP0009780_abnormal_chondrocyte_physiolo | 0.41706907 |
| 151 | MP0005248_abnormal_Harderian_gland | 0.40655910 |
| 152 | MP0002796_impaired_skin_barrier | 0.40576994 |
| 153 | MP0003633_abnormal_nervous_system | 0.40515824 |
| 154 | MP0005395_other_phenotype | 0.39526259 |
| 155 | MP0000230_abnormal_systemic_arterial | 0.38523987 |
| 156 | MP0004381_abnormal_hair_follicle | 0.37827317 |
| 157 | MP0002136_abnormal_kidney_physiology | 0.37741404 |
| 158 | MP0002928_abnormal_bile_duct | 0.37637079 |
| 159 | MP0004885_abnormal_endolymph | 0.37385184 |
| 160 | MP0005666_abnormal_adipose_tissue | 0.36091963 |
| 161 | MP0005058_abnormal_lysosome_morphology | 0.35867613 |
| 162 | MP0005464_abnormal_platelet_physiology | 0.34860728 |
| 163 | MP0010234_abnormal_vibrissa_follicle | 0.33673563 |
| 164 | MP0009115_abnormal_fat_cell | 0.33501111 |
| 165 | MP0008873_increased_physiological_sensi | 0.33080553 |
| 166 | MP0004883_abnormal_blood_vessel | 0.31492115 |
| 167 | MP0001853_heart_inflammation | 0.31459091 |
| 168 | MP0003300_gastrointestinal_ulcer | 0.31121914 |
| 169 | MP0002168_other_aberrant_phenotype | 0.30068981 |
| 170 | MP0003631_nervous_system_phenotype | 0.29834651 |
| 171 | MP0001881_abnormal_mammary_gland | 0.28668186 |
| 172 | MP0001765_abnormal_ion_homeostasis | 0.28046793 |
| 173 | MP0003632_abnormal_nervous_system | 0.27876550 |
| 174 | MP0009672_abnormal_birth_weight | 0.27866202 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 7.31450762 |
| 2 | Deep venous thrombosis (HP:0002625) | 7.24929473 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.09834233 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.37921842 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.36394906 |
| 6 | Xanthomatosis (HP:0000991) | 6.30997970 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 6.11935675 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.67062769 |
| 9 | Complement deficiency (HP:0004431) | 5.43689967 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.85949391 |
| 11 | Hyperammonemia (HP:0001987) | 4.64582504 |
| 12 | Joint hemorrhage (HP:0005261) | 4.52080096 |
| 13 | Hypoalphalipoproteinemia (HP:0003233) | 4.49688741 |
| 14 | Hyperglycinemia (HP:0002154) | 4.46356669 |
| 15 | Epidermoid cyst (HP:0200040) | 4.43600833 |
| 16 | Abnormality of the common coagulation pathway (HP:0010990) | 4.39741124 |
| 17 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.38002013 |
| 18 | Ketosis (HP:0001946) | 4.36771456 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.19179668 |
| 20 | Hyperglycinuria (HP:0003108) | 4.18500650 |
| 21 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.12886305 |
| 22 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.11308819 |
| 23 | Abnormality of glycine metabolism (HP:0010895) | 4.11308819 |
| 24 | Abnormality of methionine metabolism (HP:0010901) | 4.10792136 |
| 25 | Fat malabsorption (HP:0002630) | 4.07195358 |
| 26 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.94920618 |
| 27 | Abnormality of complement system (HP:0005339) | 3.87970682 |
| 28 | Hypoglycemic coma (HP:0001325) | 3.86259115 |
| 29 | Pancreatic cysts (HP:0001737) | 3.86228917 |
| 30 | Pancreatic fibrosis (HP:0100732) | 3.73081077 |
| 31 | Abnormality of the intrinsic pathway (HP:0010989) | 3.71302047 |
| 32 | Pendular nystagmus (HP:0012043) | 3.65842574 |
| 33 | Conjugated hyperbilirubinemia (HP:0002908) | 3.62683099 |
| 34 | Hypercholesterolemia (HP:0003124) | 3.53427799 |
| 35 | True hermaphroditism (HP:0010459) | 3.40841322 |
| 36 | Congenital stationary night blindness (HP:0007642) | 3.40830410 |
| 37 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.35720903 |
| 38 | Ketoacidosis (HP:0001993) | 3.27553589 |
| 39 | Hyperbilirubinemia (HP:0002904) | 3.26081327 |
| 40 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.23216803 |
| 41 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.15793801 |
| 42 | Delayed CNS myelination (HP:0002188) | 3.04127013 |
| 43 | Steatorrhea (HP:0002570) | 3.03967367 |
| 44 | Methylmalonic acidemia (HP:0002912) | 3.02208787 |
| 45 | Hyperventilation (HP:0002883) | 2.98596129 |
| 46 | Spontaneous abortion (HP:0005268) | 2.96790538 |
| 47 | Abnormality of midbrain morphology (HP:0002418) | 2.94745222 |
| 48 | Molar tooth sign on MRI (HP:0002419) | 2.94745222 |
| 49 | Myocardial infarction (HP:0001658) | 2.92383227 |
| 50 | Decreased central vision (HP:0007663) | 2.91489369 |
| 51 | Abnormality of serum amino acid levels (HP:0003112) | 2.89457003 |
| 52 | Nephronophthisis (HP:0000090) | 2.85872935 |
| 53 | Skin nodule (HP:0200036) | 2.81603743 |
| 54 | Abnormality of nucleobase metabolism (HP:0010932) | 2.80656740 |
| 55 | Keratoconus (HP:0000563) | 2.80528340 |
| 56 | Increased corneal curvature (HP:0100692) | 2.80528340 |
| 57 | Hepatocellular carcinoma (HP:0001402) | 2.79791495 |
| 58 | Abolished electroretinogram (ERG) (HP:0000550) | 2.76825753 |
| 59 | Hypochromic microcytic anemia (HP:0004840) | 2.74133111 |
| 60 | Hypoglycemic seizures (HP:0002173) | 2.71777487 |
| 61 | Abnormality of the renal cortex (HP:0011035) | 2.68312534 |
| 62 | Metabolic acidosis (HP:0001942) | 2.67888851 |
| 63 | Progressive cerebellar ataxia (HP:0002073) | 2.67482664 |
| 64 | Methylmalonic aciduria (HP:0012120) | 2.65519050 |
| 65 | Genetic anticipation (HP:0003743) | 2.63109426 |
| 66 | Amyloidosis (HP:0011034) | 2.61126620 |
| 67 | Attenuation of retinal blood vessels (HP:0007843) | 2.57590063 |
| 68 | Acanthocytosis (HP:0001927) | 2.55796949 |
| 69 | Systemic lupus erythematosus (HP:0002725) | 2.55025435 |
| 70 | Chronic hepatic failure (HP:0100626) | 2.54269413 |
| 71 | Abnormality of purine metabolism (HP:0004352) | 2.53124659 |
| 72 | Gaze-evoked nystagmus (HP:0000640) | 2.52976574 |
| 73 | Vascular calcification (HP:0004934) | 2.52294070 |
| 74 | Abnormal gallbladder morphology (HP:0012437) | 2.49372687 |
| 75 | Lethargy (HP:0001254) | 2.49297943 |
| 76 | Gout (HP:0001997) | 2.47739980 |
| 77 | Abnormality of the renal medulla (HP:0100957) | 2.46661166 |
| 78 | Cholelithiasis (HP:0001081) | 2.43650160 |
| 79 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.43156074 |
| 80 | Sensorimotor neuropathy (HP:0007141) | 2.43070818 |
| 81 | Cystic liver disease (HP:0006706) | 2.41092091 |
| 82 | Neonatal onset (HP:0003623) | 2.40630343 |
| 83 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.39117813 |
| 84 | Medial flaring of the eyebrow (HP:0010747) | 2.39065420 |
| 85 | Dicarboxylic aciduria (HP:0003215) | 2.36891511 |
| 86 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.36891511 |
| 87 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.36029222 |
| 88 | Mitral stenosis (HP:0001718) | 2.32868487 |
| 89 | Spastic diplegia (HP:0001264) | 2.32338458 |
| 90 | Irritability (HP:0000737) | 2.32302267 |
| 91 | Abnormal gallbladder physiology (HP:0012438) | 2.32271654 |
| 92 | Cholecystitis (HP:0001082) | 2.32271654 |
| 93 | Glomerulonephritis (HP:0000099) | 2.31519929 |
| 94 | Status epilepticus (HP:0002133) | 2.30114924 |
| 95 | Hypothermia (HP:0002045) | 2.28368032 |
| 96 | Fair hair (HP:0002286) | 2.26797319 |
| 97 | Renal cortical cysts (HP:0000803) | 2.26075892 |
| 98 | Cerebral edema (HP:0002181) | 2.23134520 |
| 99 | Chorioretinal atrophy (HP:0000533) | 2.22800865 |
| 100 | Cardiovascular calcification (HP:0011915) | 2.21153751 |
| 101 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.18668245 |
| 102 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.18590435 |
| 103 | Late onset (HP:0003584) | 2.15888642 |
| 104 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.14399765 |
| 105 | Brushfield spots (HP:0001088) | 2.12541365 |
| 106 | Malnutrition (HP:0004395) | 2.12165458 |
| 107 | Bile duct proliferation (HP:0001408) | 2.09667391 |
| 108 | Abnormal biliary tract physiology (HP:0012439) | 2.09667391 |
| 109 | Congenital sensorineural hearing impairment (HP:0008527) | 2.09416992 |
| 110 | Esophageal varix (HP:0002040) | 2.09359912 |
| 111 | Sclerocornea (HP:0000647) | 2.08120820 |
| 112 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.07392273 |
| 113 | Abnormality of alanine metabolism (HP:0010916) | 2.07392273 |
| 114 | Hyperalaninemia (HP:0003348) | 2.07392273 |
| 115 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.06761896 |
| 116 | Enlarged kidneys (HP:0000105) | 2.05741558 |
| 117 | Pancreatitis (HP:0001733) | 2.04638076 |
| 118 | Type II lissencephaly (HP:0007260) | 2.04470533 |
| 119 | Focal motor seizures (HP:0011153) | 2.04191275 |
| 120 | Confusion (HP:0001289) | 2.02482406 |
| 121 | Abnormality of the gallbladder (HP:0005264) | 2.02475903 |
| 122 | Short tibia (HP:0005736) | 2.01679511 |
| 123 | Abnormality of the renal collecting system (HP:0004742) | 2.01199688 |
| 124 | Gingival bleeding (HP:0000225) | 2.01196737 |
| 125 | Inability to walk (HP:0002540) | 2.01134822 |
| 126 | 3-Methylglutaconic aciduria (HP:0003535) | 1.99850211 |
| 127 | Hydroxyprolinuria (HP:0003080) | 1.98089708 |
| 128 | Abnormality of proline metabolism (HP:0010907) | 1.98089708 |
| 129 | Acute necrotizing encephalopathy (HP:0006965) | 1.97281508 |
| 130 | Back pain (HP:0003418) | 1.97250998 |
| 131 | Thyroiditis (HP:0100646) | 1.97170943 |
| 132 | Vomiting (HP:0002013) | 1.96927618 |
| 133 | Broad-based gait (HP:0002136) | 1.96243475 |
| 134 | Menorrhagia (HP:0000132) | 1.95090944 |
| 135 | Poikilocytosis (HP:0004447) | 1.93242149 |
| 136 | Furrowed tongue (HP:0000221) | 1.93239936 |
| 137 | Abnormality of DNA repair (HP:0003254) | 1.92396118 |
| 138 | Anencephaly (HP:0002323) | 1.92213662 |
| 139 | Agitation (HP:0000713) | 1.92184848 |
| 140 | Acute encephalopathy (HP:0006846) | 1.92088291 |
| 141 | Male pseudohermaphroditism (HP:0000037) | 1.91901414 |
| 142 | Osteomalacia (HP:0002749) | 1.90936263 |
| 143 | Thrombophlebitis (HP:0004418) | 1.90328152 |
| 144 | Thyroid-stimulating hormone excess (HP:0002925) | 1.87576387 |
| 145 | Rickets (HP:0002748) | 1.85746947 |
| 146 | Opisthotonus (HP:0002179) | 1.84809355 |
| 147 | Mitochondrial inheritance (HP:0001427) | 1.84496567 |
| 148 | Short 1st metacarpal (HP:0010034) | 1.83681328 |
| 149 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 1.83681328 |
| 150 | Hemorrhage of the eye (HP:0011885) | 1.83228067 |
| 151 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.83085572 |
| 152 | Progressive macrocephaly (HP:0004481) | 1.82742805 |
| 153 | Absent speech (HP:0001344) | 1.82012560 |
| 154 | Hypophosphatemic rickets (HP:0004912) | 1.81812260 |
| 155 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.80941482 |
| 156 | Absent/shortened dynein arms (HP:0200106) | 1.80941482 |
| 157 | Tetraplegia (HP:0002445) | 1.80398625 |
| 158 | Alkalosis (HP:0001948) | 1.80039071 |
| 159 | Congenital hepatic fibrosis (HP:0002612) | 1.79927973 |
| 160 | Generalized aminoaciduria (HP:0002909) | 1.79867637 |
| 161 | Asplenia (HP:0001746) | 1.78964859 |
| 162 | Gait imbalance (HP:0002141) | 1.78163828 |
| 163 | Stroke (HP:0001297) | 1.77971520 |
| 164 | Hemiparesis (HP:0001269) | 1.77398242 |
| 165 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.77279063 |
| 166 | Symptomatic seizures (HP:0011145) | 1.76392365 |
| 167 | Abnormality of vitamin B metabolism (HP:0004340) | 1.75938868 |
| 168 | Focal seizures (HP:0007359) | 1.75410793 |
| 169 | Clumsiness (HP:0002312) | 1.74787281 |
| 170 | Postaxial foot polydactyly (HP:0001830) | 1.74699724 |
| 171 | Increased CSF lactate (HP:0002490) | 1.74458858 |
| 172 | Polydipsia (HP:0001959) | 1.74315693 |
| 173 | Abnormal drinking behavior (HP:0030082) | 1.74315693 |
| 174 | Hyperglycemia (HP:0003074) | 1.72789689 |
| 175 | Genital tract atresia (HP:0001827) | 1.72665834 |
| 176 | Congenital, generalized hypertrichosis (HP:0004540) | 1.72224855 |
| 177 | Tubular atrophy (HP:0000092) | 1.72004814 |
| 178 | Stomach cancer (HP:0012126) | 1.71776907 |
| 179 | Elevated hepatic transaminases (HP:0002910) | 1.71766192 |
| 180 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.71203518 |
| 181 | Abnormality of vitamin metabolism (HP:0100508) | 1.70914640 |
| 182 | Short hallux (HP:0010109) | 1.70862723 |
| 183 | Small hand (HP:0200055) | 1.70457972 |
| 184 | Abnormal cartilage morphology (HP:0002763) | 1.68319550 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.16683874 |
| 2 | SIK1 | 4.61753826 |
| 3 | ERN1 | 4.11366824 |
| 4 | FGFR4 | 3.73362173 |
| 5 | ADRBK2 | 3.02478466 |
| 6 | INSRR | 2.97506577 |
| 7 | WNK3 | 2.92733922 |
| 8 | BMPR1B | 2.82278299 |
| 9 | TAOK3 | 2.68805404 |
| 10 | MAP4K2 | 2.63141316 |
| 11 | CASK | 2.62954904 |
| 12 | ERBB4 | 2.62268274 |
| 13 | MAP2K4 | 2.56350974 |
| 14 | NUAK1 | 2.51637868 |
| 15 | ZAK | 2.46931493 |
| 16 | EPHA4 | 2.40286309 |
| 17 | TLK1 | 2.30654859 |
| 18 | ACVR1B | 2.09986235 |
| 19 | TRIB3 | 2.03776528 |
| 20 | MAPK13 | 1.91151533 |
| 21 | MST1R | 1.84069074 |
| 22 | DAPK2 | 1.78160371 |
| 23 | PKN2 | 1.75087683 |
| 24 | MAPK11 | 1.60177686 |
| 25 | FGFR2 | 1.53205095 |
| 26 | FRK | 1.49642987 |
| 27 | PTK6 | 1.48850251 |
| 28 | LATS1 | 1.47183002 |
| 29 | WNK4 | 1.46570871 |
| 30 | PINK1 | 1.42887517 |
| 31 | MAP3K7 | 1.42025073 |
| 32 | PIK3CG | 1.41494598 |
| 33 | MARK1 | 1.38730405 |
| 34 | LMTK2 | 1.35068917 |
| 35 | OXSR1 | 1.34062030 |
| 36 | TNIK | 1.27349794 |
| 37 | JAK2 | 1.20233904 |
| 38 | TYK2 | 1.18003322 |
| 39 | STK39 | 1.16625062 |
| 40 | TRIM28 | 1.15056845 |
| 41 | MKNK2 | 1.14641068 |
| 42 | SGK3 | 1.14414593 |
| 43 | PRKAA2 | 1.13292343 |
| 44 | PLK2 | 1.10596502 |
| 45 | ERBB2 | 1.09227228 |
| 46 | DYRK2 | 1.09018963 |
| 47 | FLT3 | 1.06142797 |
| 48 | CSNK1G2 | 1.05550456 |
| 49 | SGK2 | 1.03824919 |
| 50 | MAPK12 | 1.02871679 |
| 51 | JAK1 | 1.00823390 |
| 52 | PRKCE | 0.99216624 |
| 53 | VRK1 | 0.98090187 |
| 54 | MAP2K7 | 0.98075055 |
| 55 | CSNK1G1 | 0.95623910 |
| 56 | PHKG2 | 0.95228041 |
| 57 | PHKG1 | 0.95228041 |
| 58 | BRSK2 | 0.95154698 |
| 59 | CAMK2G | 0.93466357 |
| 60 | CAMK1D | 0.93225865 |
| 61 | ABL2 | 0.92927298 |
| 62 | TXK | 0.92597555 |
| 63 | PRKCZ | 0.92540430 |
| 64 | MAPK15 | 0.90903062 |
| 65 | MAP3K4 | 0.88292185 |
| 66 | ADRBK1 | 0.88039813 |
| 67 | SGK223 | 0.86400421 |
| 68 | SGK494 | 0.86400421 |
| 69 | RIPK1 | 0.85392087 |
| 70 | PRKACG | 0.82787511 |
| 71 | STK38L | 0.82407448 |
| 72 | CSNK1G3 | 0.81053259 |
| 73 | PRKAA1 | 0.79962230 |
| 74 | MAPK4 | 0.77385517 |
| 75 | GRK6 | 0.76778174 |
| 76 | PRKCG | 0.76548068 |
| 77 | CAMKK2 | 0.76066664 |
| 78 | NEK9 | 0.75860852 |
| 79 | MAP3K2 | 0.75656953 |
| 80 | AKT3 | 0.73618733 |
| 81 | PDPK1 | 0.72427883 |
| 82 | MUSK | 0.71829021 |
| 83 | RET | 0.71232226 |
| 84 | MET | 0.70910376 |
| 85 | VRK2 | 0.68887271 |
| 86 | PNCK | 0.67656076 |
| 87 | GRK5 | 0.66386750 |
| 88 | PRKACA | 0.65947179 |
| 89 | PRKCH | 0.65236788 |
| 90 | MAPK7 | 0.64844233 |
| 91 | CAMK2A | 0.64323250 |
| 92 | FGFR3 | 0.64031572 |
| 93 | CAMK1G | 0.63628191 |
| 94 | NTRK2 | 0.63552821 |
| 95 | MAP3K13 | 0.63229020 |
| 96 | CSNK1A1 | 0.63138017 |
| 97 | CDK8 | 0.62607725 |
| 98 | MAP2K6 | 0.62458568 |
| 99 | PLK4 | 0.62411345 |
| 100 | TGFBR1 | 0.62066783 |
| 101 | KSR2 | 0.61530588 |
| 102 | CAMKK1 | 0.61359117 |
| 103 | NTRK1 | 0.61071088 |
| 104 | BCR | 0.60670898 |
| 105 | CSNK1A1L | 0.59965221 |
| 106 | RPS6KA5 | 0.59821573 |
| 107 | CDC7 | 0.59408515 |
| 108 | STK38 | 0.58974241 |
| 109 | EIF2AK3 | 0.58893408 |
| 110 | EPHB1 | 0.58068110 |
| 111 | PRKCQ | 0.55910907 |
| 112 | STK11 | 0.55764240 |
| 113 | NLK | 0.55253232 |
| 114 | CSNK1D | 0.55237399 |
| 115 | PAK3 | 0.54650149 |
| 116 | CAMK1 | 0.53175331 |
| 117 | BMX | 0.52737258 |
| 118 | PTK2 | 0.52585754 |
| 119 | OBSCN | 0.52464100 |
| 120 | PDK1 | 0.51898786 |
| 121 | ERBB3 | 0.51806033 |
| 122 | PDGFRA | 0.51484239 |
| 123 | DYRK3 | 0.50123698 |
| 124 | PKN1 | 0.49080075 |
| 125 | PLK3 | 0.48328913 |
| 126 | IGF1R | 0.47818348 |
| 127 | TBK1 | 0.47296747 |
| 128 | IKBKB | 0.46508909 |
| 129 | TEC | 0.46452662 |
| 130 | KDR | 0.46404769 |
| 131 | GSK3A | 0.46340003 |
| 132 | MAP3K1 | 0.45731025 |
| 133 | DYRK1B | 0.44586780 |
| 134 | STK3 | 0.44101007 |
| 135 | PRKCI | 0.43880082 |
| 136 | PRKG1 | 0.43392022 |
| 137 | NTRK3 | 0.43153299 |
| 138 | DYRK1A | 0.43107279 |
| 139 | CDK6 | 0.43042596 |
| 140 | PRKD2 | 0.42533874 |
| 141 | MAP2K1 | 0.41703694 |
| 142 | GRK1 | 0.41671474 |
| 143 | STK16 | 0.41107134 |
| 144 | PRKCA | 0.41044284 |
| 145 | FER | 0.40761756 |
| 146 | CAMK4 | 0.39112975 |
| 147 | MAP3K9 | 0.38893813 |
| 148 | MAPKAPK5 | 0.38882851 |
| 149 | EPHA3 | 0.38676518 |
| 150 | GRK7 | 0.38656390 |
| 151 | WEE1 | 0.38282998 |
| 152 | ATR | 0.38024993 |
| 153 | SGK1 | 0.37822116 |
| 154 | MAP2K3 | 0.36794261 |
| 155 | CSK | 0.36788744 |
| 156 | PDK4 | 0.36431089 |
| 157 | PDK3 | 0.36431089 |
| 158 | IRAK3 | 0.36242295 |
| 159 | RPS6KA3 | 0.35758119 |
| 160 | MAP3K3 | 0.35358795 |
| 161 | TAOK2 | 0.35328952 |
| 162 | TIE1 | 0.33516344 |
| 163 | ICK | 0.32971817 |
| 164 | PIK3CA | 0.32229307 |
| 165 | MAP3K10 | 0.31378971 |
| 166 | IRAK2 | 0.30589284 |
| 167 | MAP3K11 | 0.30528760 |
| 168 | LATS2 | 0.30465232 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.43202447 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.38828094 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.30314433 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.17291593 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.12277853 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.67378967 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.63598342 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.58176012 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.56286500 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.54942797 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.42601738 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.37851552 |
| 13 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.13858967 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.04911406 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.00068695 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.00046021 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.93386165 |
| 18 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.92093437 |
| 19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.91275985 |
| 20 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.88763007 |
| 21 | Nicotine addiction_Homo sapiens_hsa05033 | 1.86567026 |
| 22 | Phototransduction_Homo sapiens_hsa04744 | 1.85566629 |
| 23 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.79561285 |
| 24 | Histidine metabolism_Homo sapiens_hsa00340 | 1.78598469 |
| 25 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.75484589 |
| 26 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.74344126 |
| 27 | Bile secretion_Homo sapiens_hsa04976 | 1.67059631 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.65425270 |
| 29 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.62548057 |
| 30 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.58869048 |
| 31 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.55012472 |
| 32 | Retinol metabolism_Homo sapiens_hsa00830 | 1.54360039 |
| 33 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.49921310 |
| 34 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.49417823 |
| 35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.47808670 |
| 36 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.47411382 |
| 37 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.44438595 |
| 38 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.43348673 |
| 39 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.40601157 |
| 40 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.39806228 |
| 41 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.39658181 |
| 42 | * Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.36247215 |
| 43 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.35073060 |
| 44 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.31091012 |
| 45 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.29134394 |
| 46 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.27284935 |
| 47 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.25546411 |
| 48 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.24346574 |
| 49 | ABC transporters_Homo sapiens_hsa02010 | 1.23310593 |
| 50 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.18527524 |
| 51 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.11804588 |
| 52 | Homologous recombination_Homo sapiens_hsa03440 | 1.11428507 |
| 53 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.11121812 |
| 54 | Carbon metabolism_Homo sapiens_hsa01200 | 1.09436607 |
| 55 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.08983293 |
| 56 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.06702633 |
| 57 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.05933027 |
| 58 | Parkinsons disease_Homo sapiens_hsa05012 | 1.05688659 |
| 59 | Protein export_Homo sapiens_hsa03060 | 1.04341384 |
| 60 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.03998165 |
| 61 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.01916866 |
| 62 | Morphine addiction_Homo sapiens_hsa05032 | 1.01711397 |
| 63 | Taste transduction_Homo sapiens_hsa04742 | 1.00985983 |
| 64 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.99219149 |
| 65 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.97068473 |
| 66 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.96283498 |
| 67 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.95054438 |
| 68 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.93889627 |
| 69 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.92787696 |
| 70 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.92432801 |
| 71 | Olfactory transduction_Homo sapiens_hsa04740 | 0.88302507 |
| 72 | RNA polymerase_Homo sapiens_hsa03020 | 0.85154286 |
| 73 | Sulfur relay system_Homo sapiens_hsa04122 | 0.83870459 |
| 74 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.82574726 |
| 75 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.82100070 |
| 76 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.81811350 |
| 77 | Basal transcription factors_Homo sapiens_hsa03022 | 0.79414088 |
| 78 | Lysine degradation_Homo sapiens_hsa00310 | 0.77557312 |
| 79 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.76107482 |
| 80 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.75709466 |
| 81 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.75114223 |
| 82 | RNA degradation_Homo sapiens_hsa03018 | 0.70424647 |
| 83 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.69827393 |
| 84 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.69573684 |
| 85 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.66214029 |
| 86 | Alzheimers disease_Homo sapiens_hsa05010 | 0.65869714 |
| 87 | Huntingtons disease_Homo sapiens_hsa05016 | 0.65813317 |
| 88 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.65125585 |
| 89 | Circadian entrainment_Homo sapiens_hsa04713 | 0.59376849 |
| 90 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.51650128 |
| 91 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.50899738 |
| 92 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.49433529 |
| 93 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.46352189 |
| 94 | Prion diseases_Homo sapiens_hsa05020 | 0.43721823 |
| 95 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.41506290 |
| 96 | Metabolic pathways_Homo sapiens_hsa01100 | 0.41214614 |
| 97 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.38343900 |
| 98 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.36557064 |
| 99 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.33476469 |
| 100 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.32413217 |
| 101 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.31053989 |
| 102 | Cocaine addiction_Homo sapiens_hsa05030 | 0.31044835 |
| 103 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.30035896 |
| 104 | Salivary secretion_Homo sapiens_hsa04970 | 0.30012543 |
| 105 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.28796043 |
| 106 | Insulin resistance_Homo sapiens_hsa04931 | 0.28577005 |
| 107 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.28111888 |
| 108 | Galactose metabolism_Homo sapiens_hsa00052 | 0.27991391 |
| 109 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25635691 |
| 110 | Purine metabolism_Homo sapiens_hsa00230 | 0.21795557 |
| 111 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.20720544 |
| 112 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.20272716 |
| 113 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.18143499 |
| 114 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.08271232 |
| 115 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.04369953 |
| 116 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.03753128 |
| 117 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.00796556 |
| 118 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.00724609 |
| 119 | Hepatitis C_Homo sapiens_hsa05160 | -0.1885329 |
| 120 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.1830223 |
| 121 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1707284 |
| 122 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1649622 |
| 123 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1636601 |
| 124 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.1626686 |
| 125 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1582718 |
| 126 | Insulin secretion_Homo sapiens_hsa04911 | -0.1544875 |
| 127 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | -0.1419670 |
| 128 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1418895 |
| 129 | Mineral absorption_Homo sapiens_hsa04978 | -0.1326729 |
| 130 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1326500 |
| 131 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1265477 |
| 132 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.1236306 |
| 133 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.0972055 |
| 134 | GABAergic synapse_Homo sapiens_hsa04727 | -0.0447862 |
| 135 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0276129 |
| 136 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0251867 |

